Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Imatinib-Based Chemotherapy for Newly Diagnosed BCR–ABL Positive Acute Lymphoblastic Leukemia: Japan Adult Leukemia Study Group (JALSG) Ph+ALL208 Study

Shin Fujisawa, MD, Keitaro Matsuo, MD, PhD, Shuichi Mizuta, MD, Hideki Akiyama, MD, Yasunori Ueda, MD PhD, Yasutaka Aoyama, MD, Yoshihiro Hatta, MD, Kazuhiko Kakihana, MD PhD, Nobuaki Dobashi, MD, Isamu Sugiura, MD PhD, Yasushi Onishi, MD PhD, Tomoya Maeda, MD PhD, Kiyotoshi Imai, MD PhD, Shigeki Ohtake, MD PhD, Yasushi Miyazaki, MD, Kazunori Ohnishi, MD PhD, Tomoki Naoe, MDPhD

Blood (2014) 124 (21): 932.

https://doi.org/10.1182/blood.V124.21.932.932

Published: 2014

Journal Articles

Long-Term Effects of Kidney Shielding During Total Body Irradiation: A Single Institution Experience

Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD, PhD, Kazuteru Ohashi, MD, Hisashi Sakamaki, MD, PhD, Katsuyuki Karasawa, MD, PhD, Hideki Akiyama, MD, PhD

Blood (2011) 118 (21): 4475.

https://doi.org/10.1182/blood.V118.21.4475.4475

Published: 2011

Journal Articles

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

Saiko Kurosawa, Kimikazu Yakushijin, Takuhiro Yamaguchi, Yoshiko Atsuta, Tokiko Nagamura-Inoue, Hideki Akiyama, Shuichi Taniguchi, Koichi Miyamura, Satoshi Takahashi, Tetsuya Eto, Yasuo Morishima, MD, Hisashi Sakamaki, Takahiro Fukuda

Blood (2010) 116 (21): 901.

https://doi.org/10.1182/blood.V116.21.901.901

Published: 2010

Journal Articles

Morbidity and Mortality Later Than 2 Years After HSCT. A Sinle Institution Experience.

Hideki Akiyama, MD, PhD, Wataru Munakata, Takeshi Kobayashi, Kazuhiko Kakihana, Takuya Yamashita, Kazuteru Ohashi, MD, FACP, Hisashi Sakamaki

Blood (2010) 116 (21): 4508.

https://doi.org/10.1182/blood.V116.21.4508.4508

Published: 2010

Journal Articles

Sustained Superior Long-Term Outcomes of Imatinib Therapy In Japanese Patients with Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase: Sub-Analysis According to the Mean Daily Dose of Imatinib and the Plasma Trough Levels In JALSG CML202 Study After 66 Months Follow-up.

Blood (2010) 116 (21): 3417.

https://doi.org/10.1182/blood.V116.21.3417.3417

Published: 2010

Journal Articles

Chronic Kidney Disease and That Risk Factor In Patients Alive More Than 10 Years After Allogenic Hematopoietic Stem Cell Transplantation.

Tatsunori Shimoi, Minoru Ando, Takeshi Kobayashi, Kazuhiko Kakihana, Takuya Yamashita, Kazuteru Ohashi, MD, FACP, Hideki Akiyama, MD, Hisashi Sakamaki

Blood (2010) 116 (21): 3463.

https://doi.org/10.1182/blood.V116.21.3463.3463

Published: 2010

Journal Articles

A Clinical Pharmacology and Exploratory Study of Azacitidine Administered Subcutaneously or Intravenously In Japanese Patients with Myelodysplastic Syndrome

Yukio Kobayashi, MD, PhD, Michinori Ogura, MD, PhD, Kiyoshi Ando, MD, PhD, Kensei Tobinai, MD, PhD, Toshiki Uchida, MD, PhD, Yoshiaki Ogawa, MD, PhD, Takayuki Ishikawa, MD, PhD, Haruhiko Ohashi, MD, PhD, Tomoko Hata, MD, PhD, Noriko Usui, MD, PhD, Masafumi Taniwaki, MD, PhD, Kazunori Ohnishi, MD, PhD, Hideki Akiyama, MD, PhD, Keiya Ozawa, MD, PhD, Kazuma Ohyashiki, MD, PhD, Shinichiro Okamoto, MD, PhD, Akihiro Tomita, MD, PhD, Shinji Nakao, MD, PhD, Tomomitsu Hotta, MD, PhD

Blood (2010) 116 (21): 4964.

https://doi.org/10.1182/blood.V116.21.4964.4964

Published: 2010

Journal Articles

Dasatinib Compared with Imatinib In Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase (CML-CP):Results of Japanese Subset Analysis In DASISION Trial.

Michinori Ogura, MD, PhD, Hirohisa Nakamae, MD, PhD, Shin Fujisawa, MD, PhD, Kenichi Ishizawa, MD, Masafumi Taniwaki, MD, PhD, Atae Utsunomiya, MD, PhD, Kosei Matsue, MD, PhD, Kazuo Tamura, MD, Kensuke Usuki, MD, PhD, Mitsune Tanimoto, MD, PhD, Yoji Ishida, MD, PhD, Hideki Akiyama, MD, PhD, Rika Sakai, MD, PhD, Masanobu Kasai, MD, PhD, Masayuki Hino, MD, PhD, Kyoji Ueda, MD, PhD, Taku Seriu, MD, PhD, M. Brigid Bradley-Garelik, MD, Chao Zhu, PhD

Blood (2010) 116 (21): 4484.

https://doi.org/10.1182/blood.V116.21.4484.4484

Published: 2010

Journal Articles

Early Detection of Isohemagglutinin From Donor Lymphocytes Has Impact On Acute Graft-Versus-Host Disease After Minor ABO-Incompatible Hematopoietic Stem Cell Transplantation.

Izumi Kamiya, Takuya Yamashita, Kyoko Haraguchi, Taku Kikuchi, Ryo Hanajiri, Shihoko Wakabayashi, Kenichi Taoka, Takeshi Kobayashi, Kazuteru Ohashi, Hisashi Sakamaki, Yoshiki Okuyama, Hideki Akiyama

Blood (2009) 114 (22): 1150.

https://doi.org/10.1182/blood.V114.22.1150.1150

Published: 2009

Journal Articles

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Akio Shigematsu, MD, PhD, Junji Tanaka, MD, PhD, Ritsuro Suzuki, MD, PhD, Takakazu Kawase, MD, PhD, Hideki Akiyama, Takahiro Fukuda, Keiki Kumano, MD, PhD, Fumiaki Yoshiba, Heiwa Kanamori, Naoki Kobayashi, Takashi Fukuhara, Masahiro Imamura, MD, PhD

Blood (2009) 114 (22): 2306.

https://doi.org/10.1182/blood.V114.22.2306.2306

Published: 2009

Journal Articles

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Yoshihiro Hatta, Shuichi Mizuta, Shigeki Ohtake, MD, PhD, Isamu Sugiura, MD, PhD, Yasunori Ueda, MD, Heiwa Kanamori, Hideki Akiyama, Makoto Takeuchi, Noriko Usui, Toshiaki Yujiri, Atsushi Fujieda, Toru Kiguchi, MD, Itsuro Jinnai, MD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 3090.

https://doi.org/10.1182/blood.V114.22.3090.3090

Published: 2009

Journal Articles

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Shuichi Mizuta, Masamitsu Yanada, Isamu Sugiura, Fumiharu Yagasaki, Toshiaki Yujiri, Makoto Takeuchi, Yoshihiro Hatta, Yukihiko Kimura, Yasunori Ueda, MD, Heiwa Kanamori, Noriko Usui, Hideki Akiyama, Yasushi Miyazaki, MD, PhD, Shigeki Ohtake, Itsuro Jinnai, MD, Keitaro Matsuo, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 462.

https://doi.org/10.1182/blood.V112.11.462.462

Published: 2008

Journal Articles

Macrophage Colony-Stimulating Factor Attenuated the Severity of Chronic Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

Fumihiko Kimura, Ken Sato, Hideki Akiyama, Hiroshi Sao, Shin-ichiro Okamoto, MD, PhD, Naoki Kobayashi, Masamichi Hara, Keisei Kawa, Kazuo Motoyoshi

Blood (2008) 112 (11): 463.

https://doi.org/10.1182/blood.V112.11.463.463

Published: 2008

Journal Articles

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

Shigeo Fuji, MD, Sung-Won Kim, MD, Ken-ichi Yoshimura, PhD, Hideki Akiyama, MD, Shin-ichiro Okamoto, MD, Hiroshi Sao, MD, Junko Takita, MD, Naoki Kobayashi, MD, Shin-ichiro Mori, MD

Blood (2008) 112 (11): 4346.

https://doi.org/10.1182/blood.V112.11.4346.4346

Published: 2008

Journal Articles

“Painless” Bone Marrow Aspiration by Slow Suctioning Does Not Affect Peripheral Blood Contamination of the Specimen: Randomized Prospective Crossover Trials

Yuki Asano-Mori, MD, PhD, Shin-ichiro Mori, MD, Toshimitsu Ueki, MD, Miwa Sakai, MD, Takuya Yamashita, MD, PhD, Kazuteru Ohashi, MD, PhD, Hideki Akiyama, MD, PhD, Hisashi Sakamaki, MD, PhD

Blood (2008) 112 (11): 4683.

https://doi.org/10.1182/blood.V112.11.4683.4683

Published: 2008

Journal Articles

Cystatin C Level as a Marker of Renal Function in Hematopoietic Stem Cell Transplantation

Hideharu Muto, Kazuteru Ohashi, Minoru Ando, Ryo Hanajiri, Taku Kikuchi, Wataru Munakata, Chihiro Sakurai, Masahide Yamamoto, Takeshi Kobayashi, Takuya Yamashita, Hideki Akiyama, Hisashi Sakamaki

Blood (2008) 112 (11): 4306.

https://doi.org/10.1182/blood.V112.11.4306.4306

Published: 2008

Journal Articles

Effects of Recipients’ Body Weight and Total Nucleated Cell Dose on Outcomes of Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 3,114 Leukemia Patients from the Database of the Japan Marrow Donor Program

Takuya Yamashita, Hideki Akiyama, Kazuteru Ohashi, Makoto Onizuka, Shin-ichiro Mori, Hiroshi Sao, Koichi Miyamura, Hisashi Sakamaki

Blood (2008) 112 (11): 3010.

https://doi.org/10.1182/blood.V112.11.3010.3010

Published: 2008

Journal Articles

Effects of Recipients’ Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.

Takuya Yamashita, MD, Kazuteru Ohashi, M.D., Hideki Akiyama, M.D., Hisashi Sakamaki, M.D.

Blood (2007) 110 (11): 5083.

https://doi.org/10.1182/blood.V110.11.5083.5083

Published: 2007

Journal Articles

Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.

Kazunori Ohnishi, Miki Nishimura, Jin Takeuchi, Shin Fujisawa, Tadashi Nagai, Koichi Miyamura, Yukihiko Kimura, Fumiharu Yagasaki, Hideki Akiyama, Noriko Usui, Shigeki Ohtake, on behalf of JALSG

Blood (2007) 110 (11): 1044.

https://doi.org/10.1182/blood.V110.11.1044.1044

Published: 2007

Journal Articles

Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

Yuho Najima, MD, Kazuteru Ohashi, MD,FACP, Kazuhiko Kakihana, MD,PhD, Taku Kikuchi, MD, Yasunobu Nagata, MD, Chihiro Sakurai, MD, Toshimitsu Ueki, MD, Takeshi Kobayashi, MD, Takuya Yamashita, MD, Machiko Kawamura, MD,PhD, Hideki Akiyama, MD,PhD, Hidefumi Kaku, MD,PhD, Hisashi Sakamaki, MD,PhD

Blood (2007) 110 (11): 4249.

https://doi.org/10.1182/blood.V110.11.4249.4249

Published: 2007

NARROW

Imatinib-Based Chemotherapy for Newly Diagnosed BCR–ABL Positive Acute Lymphoblastic Leukemia: Japan Adult Leukemia Study Group (JALSG) Ph+ALL208 Study

Long-Term Effects of Kidney Shielding During Total Body Irradiation: A Single Institution Experience

Changes In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?

Morbidity and Mortality Later Than 2 Years After HSCT. A Sinle Institution Experience.

Sustained Superior Long-Term Outcomes of Imatinib Therapy In Japanese Patients with Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase: Sub-Analysis According to the Mean Daily Dose of Imatinib and the Plasma Trough Levels In JALSG CML202 Study After 66 Months Follow-up.

Chronic Kidney Disease and That Risk Factor In Patients Alive More Than 10 Years After Allogenic Hematopoietic Stem Cell Transplantation.

A Clinical Pharmacology and Exploratory Study of Azacitidine Administered Subcutaneously or Intravenously In Japanese Patients with Myelodysplastic Syndrome

Dasatinib Compared with Imatinib In Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase (CML-CP):Results of Japanese Subset Analysis In DASISION Trial.

Early Detection of Isohemagglutinin From Donor Lymphocytes Has Impact On Acute Graft-Versus-Host Disease After Minor ABO-Incompatible Hematopoietic Stem Cell Transplantation.

Superior Outcomes Using Medium-Dose VP-16/CY/TBI to CY/TBI as a Conditioning Regimen for Allogeneic Stem Cell Transplantation for Adult Patients with Acute Lymphoblastic Leukemia.

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Macrophage Colony-Stimulating Factor Attenuated the Severity of Chronic Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation

Obesity Is Associated with An Increased Risk of Infectious Diseases after Unrelated Bone Marrow Transplantation

“Painless” Bone Marrow Aspiration by Slow Suctioning Does Not Affect Peripheral Blood Contamination of the Specimen: Randomized Prospective Crossover Trials

Cystatin C Level as a Marker of Renal Function in Hematopoietic Stem Cell Transplantation

Effects of Recipients’ Body Weight and Total Nucleated Cell Dose on Outcomes of Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 3,114 Leukemia Patients from the Database of the Japan Marrow Donor Program

Effects of Recipients’ Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.

Lower Dose of Imatinib Provides Outcomes Similar to the Standard Dose Imatinib in Japanese Patients with Early Chronic-Phase CML: The Interim Analyses of JALSG CML202 Study.

Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only